Drug Information Association Logo

DIA 2014 9th Annual India Conference: The Future of Indian Health Care: Patients, Access and Innovation

Oct 16 2014 7:00AM - Oct 18 2014 6:00PM | Palladium Hotel, Mumbai 462, Senapati Bapat Marg, Lower Parel, Mumbai 400013 India

« Back to Listing

Overview 

Good health is a fundamental human right. But despite rapid improvements in the recent past, there are unprecedented healthcare challenges in India today that demand immediate attention and action. The most critical aspect among these is ensuring safety, efficacy, quality, affordability and accessibility of medicines and treatment to patients at all times. The key imperatives to overcome these continual challenges and catalyze the transformation include putting patients first,  fostering innovation, and enhancing access. This unique conference will bring together leading local and global experts in healthcare, pharmaceutical industry members, academia, researchers, regulators, payers and patients under one roof to deliberate on the emerging trends, opportunities and challenges.

Featured Topics 

Program Objectives:
  • Focusing on ‘Patient First’ approach and various patient centric paradigms covering patient, innovation and access of Indian healthcare
  • Hear directly from leading experts from the academia, government, industry, researchers, patient representative and regulators their views on current local and global trends and best practices
  • Covering important issues/topics: patient health & safety, pharmacovigilance, clinical trial, quality and manufacturing, health economics, healthcare delivery, public-private partnership in innovation and healthcare access, case studies on Indian innovation and many more
  • Bringing all healthcare stakeholders together to discuss current issues/topics

Who Should Attend 

  • Drug development and clinical research managers and associates
  • Pharmaceutical physicians and medical directors
  • Drug safety and drug surveillance personnel
  • Professionals engaged in discovery research
  • Clinical pharmacology scientists
  • Pharmacologists
  • Regulatory affairs managers
  • Regulators
  • Quality professionals
  • Academic scientists
  • Biostatisticians
  • Data managers
  • Medical writers
  • Outsourcing and marketing managers
  • IT professionals
  • Students

Contact Information 

Manoj Trivedi, Senior Manager Marketing and Program Development, DIA India
Mobile phone: +91-98-1977-7493
Phone: +91-22-6765-3226
Email: Manoj.Trivedi@diaindia.org

Rajnish Kumar
DIA India/CIMGlobal Sales Lead
Mobile phone: +91.98.1909.8457
Email: rajnish.kumar@diaindia.org

 

Featured Speaker 

Previous Next

Program Committee 

Previous Next

Agenda  

Day 1 Thursday, Oct 16, 2014

  • 10:30AM - 11:00AM

    Day 1 Keynote

    Speaker(s):

    • M. K. Bhan
      Former Secretary, Department of Biotechnology (DBT)
      Government of India, India
  • 11:00AM - 12:00PM

    Plenary Session 1 - Patients


    Session Chair(s):

    • Vikas Mohan Sharma, MD
      Senior Director, Medical Ethics & Research Office of CMO
      Quintiles Technologies India Pvt. Ltd., India

    Speaker(s):

    • Bhasker Iyer
      Divisional Vice President, India Commercial Operations
      Abbott Healthcare , India
    • Urmila Thatte
      Director, FERCI, Prof. and Head, Deptartment of Clinical Pharmacology
      KEM Hospital, India
    • Satish Chandra
      Senior Specialist and Head Clinical Research
      TAWAM Hospital (associate of John Hopkins), United Arab Emirates
    • Y. K. Gupta
      Prof. & Head, Department of Pharmacology
      All India Institute of Medical Sciences, India
    • Pooja Sharma
      Patient Advocacy Groups
      CANKIDS, India
  • 1:30PM - 3:00PM

    Session 1B


    Session Chair(s):

    • Ajoy Roy
      Senior Medical Director and Head Medical Affairs
      Parexel,India, India

    This session will describe the status of pharmacovigilance regulation and practices in India, with a focus on monitoring the safe use of markets drugs and ways to take prompt remedial action when and if necessary.

    Speaker(s):

    • Postmarketing Pharmacovigilance Regulations and Practices in India
      Y. K. Gupta
      Prof. & Head, Department of Pharmacology
      All India Institute of Medical Sciences, India
    • Clinical Trials Safety Regulations in India - Current Scenario and Global Perspective
      Vivek Ahuja
      Director
      PATH, India
    • A SWOT Analysis of Growing Pharmacovigilance Industry in India
      Adnan Mahmood
      Director- Medical Safety & Clinical Development
      Global Patient Safety, United Kingdom
  • 3:30PM - 5:00PM

    Session 2A - Status of Patient Advocacy Groups in India


    Session Chair(s):

    • Mira Shiva
      Founder
      Health Action International Asia Pacific , India

    This session will provide current information on the status and influence of patient advocacy groups in India, their goals and aspirations, their success and ongoing concerns, and the issues that remain to be addressed to protect patient safety and promote patient health.

    Speaker(s):

    • Y K Sapru
      Cancer Patients Aid Association , India
    • Vikas Ahuja
      President
      The Delhi Network of Positive People , India
    • Ketho Angami
      Executive Member
      HepCoN , India
  • 3:30PM - 5:00PM

    Session 2B - Patient Participation in Clinical Trial


    Session Chair(s):

    • Barbara Bierer, MD
      Senior Vice President of Research; Professor of Medicine
      Harvard Medical School; Brigham and Women's Hospital, United States

Day 2 Friday, Oct 17, 2014

  • 10:30AM - 11:00AM

    Day 2 Keynote

    Speaker(s):

    • G. N. Singh
      Drug Controller General of India (DCGI)
      India
  • 11:00AM - 12:30PM

    Plenary Session 2 - Access


    Session Chair(s):

    • Nata Menabde
      Representative to India
      WHO, India

    Speaker(s):

    • Swati A. Piramal, MPH
      Director, Strategic Alliances and Communications
      Nicholas Piramal India Limited, India
    • Nirmal K. Ganguly
      Former Director General
      Indian Council of Medical Research (ICMR), India
    • Devi Shetty
      Chairman
      Narayana Hrudayalaya Group of Hospitals, India
    • Rajesh Balkrishnan
      Associate Professor Health Outcomes
      University of Michigan, United States
    • Ferzaan Engineer
      Co-Founder and Chairman
      Cytespace , India
  • 1:30PM - 3:00PM

    Session 3A - Universal Health Coverage and Health Insurance


    Session Chair(s):

    • Antonio Duran
      Technical Advisor
      WHO India, India

    Speaker(s):

    • Access to Medicines and Health Technologies in the Context of Universal Healthcare Coverage in India: Opportunities and Challenges
      Madhur Gupta
      Technical Officer - Pharmaceuticals
      WHO, India
    • No-Return Progress Without Maximalist Attitudes: The India Way Towards Universal Health Coverage
      Antonio Duran
      Technical Advisor
      WHO India, India
    • Indrani Gupta
      Institute of Economic Growth , India
  • 1:30PM - 3:00PM

    Session 3B - Medicine Pricing and Reimbursement


    Session Chair(s):

    • Manu Sehgal
      Vice President
      PAREXEL , India

    Speakers in this session will illustrate the various existing public and private mechanisms for the pricing and reimbursement of medicines in India, with a focus on how patients at all income levels can have access to the medicines they need, on what obstacles may exist to such access, and on possible ways to remove such obstacles.

    Speaker(s):

    • Insight into India's Pharmaceutical Pricing Policy: Will the Revised Policy Improve Access to Medicines?
      Anita Kotwani
      Associate Professor
      Chest institute, Delhi University, India
    • Anuj Kapoor
      Senior Manager Operations
      Optum Global Solutions, India
  • 3:30PM - 5:00PM

    Session 4A- Good Manufacturing Practices


    Session Chair(s):

    • Representative Invited
      United States

    Pharmaceutical GMP in modern times is not just an assessment through testing the finished product but is an ongoing discipline that one has to be imbibe from product development to product distributed the patients. GMP poses a significant challenges in terms of bridging – What Agency Wants and What Industry Understands. This GMP session covers the current GMP challenges of Indian Pharmaceutical/Healthcare industry and the path to be traversed moving forward.

  • 3:30PM - 5:00PM

    Session 4 B - Compulsory Licensing -Increasing Tool for Easy Access of Medicines


    Session Chair(s):

    • Aliasgar Dholkawala
      Senior Associate, Legal Services
      Wadia Ghandy & Co,, India

    This session will examine and debate the important and delicate issue of compulsory licensing of medicines and both its intended (affordable access to medicines) and unintended (obstacle to theentry of innovation into India) consequences.

    Speaker(s):

    • Milind Sathe
      Dy. General Manager, IPM & Projects
      Unichem, India
    • Alka Mehta
      Regulatory Affairs
      Cipla Ltd., India
    • Tabrez Ahmad
      Secretary General
      OPPI, India

Day 3 Saturday, Oct 18, 2014

  • 9:30AM - 10:00AM

    Day 3 Keynote

    Speaker(s):

    • Kiran Mazumdar-Shaw, MD
      Chairman and Managing Director; Founder Entrepreneur
      Biocon, Ltd., India
  • 10:30AM - 11:30AM

    Plenary Session 3 - Innovations


    Session Chair(s):

    • No-image Arun Mishra
      Director and Head, Regulatory Affairs
      Abbott India Ltd., India

    Speaker(s):

    • V. V. S. Swaroop
      CEO
      Incozen Therapeutics Vaccines, India
    • Padmashree Prof. Ranjit Roy Chaudhury
      Chairman, Task Force for Clinical Research
      Apollo Hospitals Group, India
    • Mohan D Nair
      Consultant
      Consultant to Pharmaceutical Industry, India
    • Romi Singh, PhD
      Executive Director, Global Regulatory Affairs and Safety
      Amgen Inc., United States
  • 11:30AM - 1:00PM

    Session 5 - Innovation in Drug Discovery and Development


    Session Chair(s):

    • Neelima Khairatkar Joshi
      Senior Vice President and Head NCE Drug Discovery & Research
      Glenmark, India

    Speakers in this session will illustrate the current status of pharmaceutical innovation in India – from scientific discovery to the development of innovative drugs that change the practice of medicine. Can Indian R&D improve its competitiveness on world markets?

    Speaker(s):

    • Latest Trend in Cancer Therapy
      V. V. S. Swaroop
      CEO
      Incozen Therapeutics Vaccines, India
    • The need for New Innovative Approaches to New Drug Discovery
      Mohan D Nair
      Consultant
      Consultant to Pharmaceutical Industry, India
  • 2:00PM - 4:00PM

    Session 6


    Session Chair(s):

    • Sudharshan Jain
      Managing Director, Healthcare Solutions
      Abbott India, India

    This session will address examples of how certain Indian healthcare solutions have been highly innovative and have delivered concrete benefits to millions of patients. Speakers will address what additional actions need to be taken to expand such innovation to the entire Indian patient population.

    Speaker(s):

    • Affordable Healthcare Driving Reverse Innovation .... A New Normal in the Bipolar World
      Abhishek Bhattacharya
      Vice President, Life Sciences Operations
      Accenture Services Pvt. Ltd., India
    • Indigenous Innovation in Medical Technology : An Emerging Paradigm
      Siraj Dhanani
      Founder & CEO
      Innaccel Pvt. Ltd., India
    • Empowering Frontline Health Workers with Technology
      Kanav Kahol
      Principal Sales Consulting Head
      Public Health Foundation of India, India
    • Big Data Analytics for Developing Nations: How Secondary use of EHR Data can help India
      Gunjan Jain
      Solution Consultant, Oracle Health Sciences
      Oracle, India

Exhibits  

The DIA 2014 9th Annual India Conference offers interested companies that opportunity to exhibit with a booth. Additional advertising and support opportunities also available.

Useful Links:

  • Glenmark Pharmaceuticals Limited
  • Lambda Therapeutic Research Private Limited
  • LORENZ Life Sciences India Pvt. Ltd.
  • Quintiles Technologies (India) Private Limited
  • Tata Consultancy Services
  • the Uppsala Monitoring Centre

Registration Fees 

Other Fees

Indian Government (Full Time)
Rs6000.00
Indian Government (Full Time) (As of 09/01/2014)
Rs7000.00
Indian Academia
Rs6000.00
Indian Academia (As of 09/01/2014)
Rs7000.00

Member

Indian Member Standard
Rs9000.00
Indian Member Standard (As of 09/01/2014)
Rs10000.00
Int'l Member Rate ($300)
Rs18000.00

Non-Member

Indian NonMember Standard
Rs11000.00
Indian NonMember Standard (As of 09/01/2014)
Rs12000.00
Int'l NonMember Rate ($475)
Rs28500.00
Group Discounts

There are no group discounts for this event.


Find out more about the many benefits of membership and how you can get involved.


A limited number of student registrations are available. A student is an undergraduate/graduate who can document enrollment in a Signature accredited, degree granting, academic program. Please send completed registration form, copy of student identification, and payment.


CANCELLATION POLICY: On or before OCTOBER 2, 2014

Cancellations must be in writing and received by October 2, 2014. Registrants who do not cancel in writing by that date and do not attend the event will be responsible for the full registration fee paid. Registrants are responsible for cancelling their own hotel and airline reservations.

DIA reserves the right to alter the venue, if necessary. If an event is cancelled, DIA is not responsible for any airfare, hotel or other costs incurred by registrants.

Upon cancellation, the administrative fee that will be withheld is 75% of the registration fee.

All refunds will be issued in the currency of original payment

Register Online
« Back to Listing Back To Top